CNS Pharmaceutical
Houston
About CNS Pharmaceutical
CNS Pharmaceuticals is a pre-clinical stage biotechnology company specializing in the development of novel treatments for brain tumors. CNS may also pursue the development of Berubicin to treat additional diseases, including pancreatic and ovarian cancers and lymphoma. CNS may also develop combination therapies that include Berubicin.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $31.5M
- Funding stage: IPO
- Last round: Post-IPO Equity (May 2025)
- Ticker: nasdaq:CNSP
- Website: cnspharma.com
- Phone: +1 800-509-5586
Industries & Categories
Biotechnology, Life Science, Pharmaceutical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/cns-pharmaceutical-151011 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.